These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2504599)

  • 21. Analysis of cefepime tissue penetration into human appendix.
    Okamoto MP; Chin A; Gill MA; Yellin AE; Berne TV; Heseltine PN; Appleman MD; Knupp CA; Sclar DA
    Pharmacotherapy; 1991; 11(5):353-8. PubMed ID: 1745620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue concentrations of cefepime in acute cholecystitis patients.
    Okamoto MP; Gill MA; Nakahiro RK; Chin A; Yellin AE; Berne TV; Sclar DA; Knupp CA; Heseltine PN; Appleman MD
    Ther Drug Monit; 1992 Jun; 14(3):220-5. PubMed ID: 1412608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of cefpirome during continuous venovenous hemofiltration: rationale for an 8-hour dosing interval.
    Banyai M; Thalhammer F; El-Menyawi I; Heinz G; Traunmüller F; Siostrzonek P
    Clin Pharmacol Ther; 2000 Apr; 67(4):368-72. PubMed ID: 10801245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Penetration of cefpirome into sputum in chronic respiratory infections: comparison of administration of 0.5 g and 1.0 g in the same patient.
    Shishido H; Nagai H; Miyake S; Kaburagi T; Satoh K; Deguchi K
    Int J Clin Pharmacol Res; 1993; 13(4):225-9. PubMed ID: 8150549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of the pharmacokinetics of cefpirome sulphate in the elderly.
    Sugihara H; Narita N; Takatsu R; Horiuchi M; Yonenami K; Hotta M; Shibahara K; Kamo T; Negishi Y
    J Clin Pharm Ther; 1998 Oct; 23(5):375-9. PubMed ID: 9875686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative in vitro activity of cefpiramide, a new parenteral cephalosporin.
    Quentin C; Noury P; Titonel M
    Eur J Clin Microbiol Infect Dis; 1988 Aug; 7(4):544-9. PubMed ID: 3141169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Penetration of cefpirome into the anterior chamber of the human eye after intravenous application.
    Egger SF; Alzner E; Georgopoulos M; Elmenyawi I; Huber-Spitzy V; Georgopoulos A; Grabner G
    J Antimicrob Chemother; 2000 Feb; 45(2):213-6. PubMed ID: 10660503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Penetration of prophylactic antibiotics into peritoneal fluid.
    Kaplan O; Berger S; Gorea A; Rozin RR; Lelcuk S
    Am J Surg; 1989 Jun; 157(6):585-7. PubMed ID: 2658640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraprostatic concentration of ciprofloxacin and its activity against urinary pathogens.
    Hoogkamp-Korstanje JA; van Oort HJ; Schipper JJ; van der Wal T
    J Antimicrob Chemother; 1984 Dec; 14(6):641-5. PubMed ID: 6440885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CP6679, a new injectable cephalosporin with broad spectrum and potent activities against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa.
    Ida T; Tsushima M; Ishii T; Atsumi K; Tamura A
    J Infect Chemother; 2002 Jun; 8(2):138-44. PubMed ID: 12111566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-dose pharmacokinetics of cefpirome in patients receiving hemodialysis and in patients treated by continuous ambulatory peritoneal dialysis.
    Veys N; Lameire N; Malerczyk V; Lehr KH; Rosenkranz B; Ringoir S
    Clin Pharmacol Ther; 1993 Oct; 54(4):395-401. PubMed ID: 8222482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population pharmacokinetics and pharmacodynamics of cefpirome in critically ill patients against Gram-negative bacteria.
    Roos JF; Lipman J; Kirkpatrick CMJ
    Intensive Care Med; 2007 May; 33(5):781-788. PubMed ID: 17342515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Sensitivity of clinical isolates of several enterobacteriaceae, pseudomonas aeruginosa, staphylococcus aureus and streptococcus faecalis to antibiotics. Results of a supraregional collaborative study of the "work-group on resistance" of the Paul Ehrlich Society for Chemotherapy (author's transl)].
    Paul-Ehrlich-Gesellschaft
    Infection; 1978; 6(1):35-44. PubMed ID: 415984
    [No Abstract]   [Full Text] [Related]  

  • 34. [Diffusion of cefpirome in ascitic fluid].
    Taugourdeau MC; Laurent-Puig P; Hagège H; Taburet AM; Etienne JP; Singlas E
    Gastroenterol Clin Biol; 1993; 17(11):878-9. PubMed ID: 8143964
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparative antimicrobial activity of FK037, cefpirome, ceftazidime and cefepime against aminoglycoside-sensitive and aminoglycoside-resistant Pseudomonas aeruginosa and Pseudomonas spp.
    Baltch AL; Smith RP; Ritz W
    Chemotherapy; 1994; 40(6):391-8. PubMed ID: 7842822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple-dose pharmacokinetics of cefpirome in long-term hemodialysis with high-flux membranes.
    Thalhammer F; Schmaldienst S; Elmenyawi I; Atteneder M; Burgmann H; Hollenstein U; Georgopoulos A; Graninger W; Putz D; Rosenkranz AR; Mayer G; Hörl WH; Breyer S
    Clin Pharmacol Ther; 1996 Dec; 60(6):645-50. PubMed ID: 8988066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative in-vitro activity of cefpirome against isolates from intensive care and haematology/oncology units. Belgian Multicentre Study Group.
    Piérard D; Emmerechts K; Lauwers S
    J Antimicrob Chemother; 1998 Apr; 41(4):443-50. PubMed ID: 9598775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The intraperitoneal penetration of temocillin.
    Wise R; Donovan IA; Drumm J; Dyas A; Cross C
    J Antimicrob Chemother; 1983 Jul; 12(1):93-6. PubMed ID: 6619048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-dose pharmacokinetics of cefpirome in patients with renal impairment.
    Lameire N; Malerczyk V; Drees B; Lehr K; Rosenkranz B
    Clin Pharmacol Ther; 1992 Jul; 52(1):24-30. PubMed ID: 1623690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antibiotic activities of cefpirome against fresh clinical isolates resistant to multiple drugs].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Nakane Y; Fukumoto T
    Jpn J Antibiot; 1994 Feb; 47(2):143-60. PubMed ID: 8151908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.